Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 9, Pages 1277
Publisher
MDPI AG
Online
2020-09-04
DOI
10.3390/biom10091277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation
- (2019) Kei Noguchi et al. PLoS One
- Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice
- (2019) Yi Peng et al. BIOMEDICINE & PHARMACOTHERAPY
- Circulating Galectin-3 and Atrial Fibrillation Recurrence after Catheter Ablation: A Meta-Analysis
- (2019) Guangping Zhang et al. Cardiovascular Therapeutics
- Biomarkers associated with 30‐day readmission and mortality after pediatric congenital heart surgery
- (2019) Devin M. Parker et al. JOURNAL OF CARDIAC SURGERY
- Galectin‐3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients
- (2019) Deepa M. Gopal et al. Journal of the American Heart Association
- Biomarkers in heart failure: the past, current and future
- (2019) Michael Sarhene et al. HEART FAILURE REVIEWS
- Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
- (2019) Jaime Ibarrola et al. Scientific Reports
- Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
- (2019) Nakajima et al. Journal of Clinical Medicine
- The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update
- (2019) Maria Arkoumani et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Cardioprotective effects of galectin-3 inhibition against ischemia/reperfusion injury
- (2019) Dan Mo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis
- (2019) Chengyan Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach
- (2019) Axel C. Carlsson et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Multiplex biomarker approach to cardiovascular diseases
- (2018) Michaela Adamcova et al. ACTA PHARMACOLOGICA SINICA
- GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
- (2018) Courtney Tuegel et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β2-adrenoceptor overexpression
- (2018) My-Nhan Nguyen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure)
- (2018) Eileen O’Meara et al. Circulation-Heart Failure
- Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
- (2018) Kathryn C. B. Tan et al. DIABETOLOGIA
- Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
- (2018) Nicolas Clementy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Galectins at a glance
- (2018) Ludger Johannes et al. JOURNAL OF CELL SCIENCE
- Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
- (2018) My-Nhan Nguyen et al. Scientific Reports
- The role of galectin-3 in heart failure and cardiovascular disease
- (2018) Xiao Zhong et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- IL-33/ST2 Axis in Organ Fibrosis
- (2018) Ourania S. Kotsiou et al. Frontiers in Immunology
- Prognostic value of galectin-3 in adults with congenital heart disease
- (2017) Vivan J M Baggen et al. HEART
- Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
- (2017) Rui Dong et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
- (2017) Laura Díaz-Alvarez et al. MEDIATORS OF INFLAMMATION
- Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
- (2017) Neal L. Millar et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus
- (2017) Christoffer T. Nielsen et al. Clinical Proteomics
- Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
- (2017) Alberto Aimo et al. JACC-Heart Failure
- Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?
- (2016) Valérie Desmedt et al. AMERICAN JOURNAL OF NEPHROLOGY
- Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis
- (2016) Olga Frunza et al. AMERICAN JOURNAL OF PATHOLOGY
- Galectin 3 as a guardian of the tumor microenvironment
- (2016) Peter P. Ruvolo BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression
- (2016) Lei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
- (2016) Giuseppe Vergaro et al. HYPERTENSION
- Genetic markers: Potential candidates for cardiovascular disease
- (2016) Riyaz Ahmad Rather et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel
- (2015) James L. Januzzi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Nonclassical Resident Macrophages Are Important Determinants in the Development of Myocardial Fibrosis
- (2015) Alec Falkenham et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression
- (2015) Xiang Song et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis
- (2015) Ming Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- Galectin-3 is expressed in the myocardium very early post–myocardial infarction
- (2015) Satwat Hashmi et al. CARDIOVASCULAR PATHOLOGY
- Urinary C-type natriuretic peptide: An emerging biomarker for heart failure and renal remodeling
- (2015) Rosita Zakeri et al. CLINICA CHIMICA ACTA
- Galectin-3 in atrial fibrillation: Simple bystander, player or both?
- (2015) Giuseppe Lippi et al. CLINICAL BIOCHEMISTRY
- Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin
- (2015) Begoña López et al. EUROPEAN JOURNAL OF HEART FAILURE
- Galectin-3 in autoimmunity and autoimmune diseases
- (2015) Felipe L de Oliveira et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma
- (2015) Masoud Zeinali et al. HUMAN IMMUNOLOGY
- The galectin lattice at a glance
- (2015) I. R. Nabi et al. JOURNAL OF CELL SCIENCE
- The potential role of IL-33/ST2 signaling in fibrotic diseases
- (2015) Qiaoyan Gao et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis
- (2015) Carolina Jaquenod De Giusti et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Early microlesion of viral encephalitis confirmed by galectin-3 expression after a virus inoculation
- (2015) Kazuhiro Kobayashi et al. NEUROSCIENCE LETTERS
- GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
- (2015) Ramu Adela et al. Journal of Diabetes Research
- Galectin-3 in cancer
- (2014) Lin Song et al. CLINICA CHIMICA ACTA
- Galectins as bacterial sensors in the host innate response
- (2014) Huan-Yuan Chen et al. CURRENT OPINION IN MICROBIOLOGY
- Galectin-3 in angiogenesis and metastasis
- (2014) T. Funasaka et al. GLYCOBIOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
- (2014) Varsha Srivatsan et al. European Journal of Preventive Cardiology
- Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
- (2014) Wouter C. Meijers et al. Journal of the American Heart Association
- Extracellular Galectin-3 in Tumor Progression and Metastasis
- (2014) Anneliese Fortuna-Costa et al. Frontiers in Oncology
- The pleiotropic effects of galectin-3 in neuroinflammation: A review
- (2013) Taekyun Shin ACTA HISTOCHEMICA
- Galectin-3: A new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure
- (2013) Nataliya Hrynchyshyn et al. Archives of Cardiovascular Diseases
- Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction
- (2013) Robin A.P. Weir et al. Circulation-Heart Failure
- The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices
- (2013) Gülsüm Erkilet et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
- (2013) Lars Wallentin et al. PLoS One
- Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
- (2013) Deepa M. Gopal et al. Journal of the American Heart Association
- The Use of Biomarkers in the Patient with Heart Failure
- (2013) Punam Chowdhury et al. Current Cardiology Reports
- Glycans, galectins, and HIV-1 infection
- (2012) Sachiko Sato et al. Annals of the New York Academy of Sciences
- Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
- (2012) Thomas J. Wang et al. CIRCULATION
- Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease
- (2012) Cristina Basso et al. HEART FAILURE REVIEWS
- The Impact of C-Reactive Protein on Risk of Stroke, Stroke Subtypes, and Ischemic Heart Disease in Middle-Aged Japanese: the Japan Public Health Center-Based Study
- (2012) Hiroyasu Iso et al. Journal of Atherosclerosis and Thrombosis
- Galectin-3 in preneoplastic lesions of glioma
- (2012) Nguyen Huy Binh et al. JOURNAL OF NEURO-ONCOLOGY
- Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
- (2012) Jennifer E. Ho et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages
- (2011) Ruder Novak et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology
- (2011) James R. Stone et al. CARDIOVASCULAR PATHOLOGY
- Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
- (2011) Natalia Lopez-Andrès et al. EUROPEAN JOURNAL OF HEART FAILURE
- The fibrosis marker galectin-3 and outcome in the general population
- (2011) R. A. de Boer et al. JOURNAL OF INTERNAL MEDICINE
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
- (2010) Rudolf A. de Boer et al. ANNALS OF MEDICINE
- HFSA 2010 Comprehensive Heart Failure Practice Guideline
- (2010) Heart Failure Society of America JOURNAL OF CARDIAC FAILURE
- Early detection of myocardial dysfunction and heart failure
- (2010) Geoffrey de Couto et al. Nature Reviews Cardiology
- Viral causes of human myocarditis
- (2009) Laurent Andréoletti et al. Archives of Cardiovascular Diseases
- C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: The JACC Study
- (2009) Hiroyasu Iso et al. ATHEROSCLEROSIS
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
- (2008) Yun-He Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The immunological potential of galectin-1 and -3
- (2008) Amy Dhirapong et al. AUTOIMMUNITY REVIEWS
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis
- (2008) EH Kang et al. LUPUS
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
- (2007) W.H. Wilson Tang et al. CLINICAL BIOCHEMISTRY
- Use of natriuretic peptides in pre-participation screening of college athletes
- (2007) Lori B. Daniels et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started